Anti-Inflammatory Peptide 1 (Synonyms: H2N-Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser-OH ) |
Catalog No.GP10124 |
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 118850-71-8
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cas No. | 118850-71-8 | SDF | |
Synonymes | H2N-Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser-OH | ||
Chemical Name | Anti-Inflammatory Peptide 1 | ||
Canonical SMILES | CC(C)CC(C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCSC)N | ||
Formula | C45H82N12O14S2 | M.Wt | 1079.33 |
Solubility | ≥107.9mg/mL in DMSO | Storage | Store at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Complete Stock Solution Preparation Table
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.9265 mL | 4.6325 mL | 9.265 mL |
5 mM | 0.1853 mL | 0.9265 mL | 1.853 mL |
10 mM | 0.0927 mL | 0.4633 mL | 0.9265 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GP10160 Oritavancin(LY-333328)
- GP10159 Urotensin II (114-124), human
- GP10085 Thrombin Receptor Activator for Peptide 5 (TRAP-5)
- GP10112 TRH Precursor Peptide
- GP10146 ferritin heavy chain fragment [Multiple species]
- GP10077 Angiotensin (1-7)
- GP10133 immunoglobulin light chain variable region fragment [Homo sapiens]/[Mus musculus]
- GP10072 Pro-Adrenomedullin (153-185), human
- GP10140 MAP kinase fragment [Multiple species]
- GP10042 Rhodopsin peptide
- GP10156 T7 Tag Peptide
- GP10152 Influenza Hemagglutinin (HA) Peptide
- GP10034 survivin (baculoviral IAP repeat-containing protein 5) (21-28)
- GP10014 parathyroid hormone (7-34) [Homo sapiens]/[Macaca fascicularis]
- GP10069 Parathyroid hormone (1-34) (human)
- GP10059 Acetyl Angiotensinogen (1-14), porcine
- GP10120 Angiotensin 1/2 + A (2 - 8)
Avis
Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *